Efficiency and safety of levoсabastine (TYZINE®ALERGY) in allergic rhinitis patients

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Own results of clinical observation about application of levoсabastine in complex therapy of allergic rhinitis are presented in the article

allergic rhinitis, H -blockers, levocabastine

##article.viewOnOriginalSite##

Institute of Immunology

Email: el-olga@yandex.ru
Moscow, Russia

Institute of Immunology

Moscow, Russia

Institute of Immunology

Moscow, Russia

Аллергология. Федеральные клинические рекомендации. Под ред. Р.М. Хаитова, Н.И. Ильиной. M., «Фармарус Принт Медиа». 2014, 126 с.
Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008, v. 86, p. 8-160.
Falser N., Wober W., Rahlfs V.W., Baehre M. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Arzneimittelforschung. 2001, v. 51, p. 387-393.
Canonica W.G., Marzetto M., Kolb С., Ellers-Lenz B. Multinational clinical trial to assess efficacy and safety of azelastine eye drops in patients with perennial allergic conjunctivitis/rhino-conjunctivitis. Annual Meeting of the European Academy of Allergology and Clinical Immunology. 2000, p. 662.
Kremer B., Tündermannb A., Goldschmidt O. et al. Effectiveness and Tolerance of Levocabastine and Nedocromil in Topical Therapy of Seasonal Allergic Rhinoconjunctivitis. Armeim. Forsch. Drug. Res. 1998, v. 48, p. 924-930.
Gerth van Wijk R. Treatment of allergic rhinoconjunctivitis a review of the role of topical levocabastine. Mediators of Inflammation. 1995, v. 4, p. 31-38.

Supplementary Files

Action

1. JATS XML